Axa’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-782,085
| Closed | -$1.24M | – | 1108 |
|
|
2023
Q1 | $1.24M | Sell |
782,085
-6,281
| -0.8% | -$9.99K | ﹤0.01% | 838 |
|
|
2022
Q4 | $4.91M | Buy |
+788,366
| New | +$4.91M | 0.02% | 607 |
|
|
2021
Q2 | – | Sell |
-127,146
| Closed | -$3.57M | – | 1264 |
|
|
2021
Q1 | $3.57M | Buy |
127,146
+36,874
| +41% | +$1.03M | 0.01% | 759 |
|
|
2020
Q4 | $2.35M | Buy |
90,272
+71,877
| +391% | +$1.87M | 0.01% | 824 |
|
|
2020
Q3 | $684K | Sell |
18,395
-186
| -1% | -$6.92K | ﹤0.01% | 991 |
|
|
2020
Q2 | $953K | Buy |
18,581
+953
| +5% | +$48.9K | ﹤0.01% | 964 |
|
|
2020
Q1 | $556K | Sell |
17,628
-64,632
| -79% | -$2.04M | ﹤0.01% | 952 |
|
|
2019
Q4 | $4.91M | Buy |
+82,260
| New | +$4.91M | 0.02% | 623 |
|
|
2018
Q2 | – | Sell |
-4,700
| Closed | -$340K | – | 1363 |
|
|
2018
Q1 | $340K | Buy |
+4,700
| New | +$340K | ﹤0.01% | 1233 |
|
|
2015
Q4 | – | Sell |
-117,703
| Closed | -$2.78M | – | 1424 |
|
|
2015
Q3 | $2.78M | Buy |
117,703
+39,612
| +51% | +$935K | 0.01% | 707 |
|
|
2015
Q2 | $6.39M | Hold |
78,091
| – | – | 0.03% | 527 |
|
|
2015
Q1 | $7.23M | Sell |
78,091
-10,455
| -12% | -$968K | 0.03% | 478 |
|
|
2014
Q4 | $3.58M | Buy |
+88,546
| New | +$3.58M | 0.01% | 645 |
|